Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Beyond B-II is a professional-grade dental whitening gel developed by Beyond International for use in aesthetic dentistry. The product is a high-concentration hydrogen peroxide formulation (typically 35%) designed for in-office teeth whitening procedures. It is frequently used in conjunction with light-accelerated whitening systems, such as the Beyond Polus, which catalyzes the decomposition of hydrogen peroxide into reactive oxygen free radicals. These radicals penetrate the tooth enamel and dentin to oxidize organic chromogens (staining molecules), effectively neutralizing discolorations caused by aging, tobacco, food, and beverages. The B-II formulation is engineered to provide rapid aesthetic results in a single clinical session while incorporating desensitizing agents to minimize patient discomfort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Beyond B-II.